Also, during STEP 5, a study to assess efficacy of semaglutide with a follow-up of 2 years, there is a post-hoc analysis that demonstrates a better performance in the self-reported Control of Eating Questionnaire(CoEQ) to measure changes in appetite versus placebo, with lower cravings for dairy and starchy foods and less desire for salty and spicy food at short-term (20 weeks) but also as a maintenance therapy at weeks 52 and 104 (178)
Such trials include investigating other GLP-1RAs use in adolescents, the use of GLP-1RAs in young children, and trials involving various possible adverse effects of using these medications in pediatric patients
Gullaksen S, Vernstrm L, Srensen SS, et al
This question was investigated in the STEP 5 trial
If you are not hungry enough, daily calorie tracking ensures you are meeting your minimums